Pregnancy outcome in patients presented with Peripartum Cardiomyopathy: A five-year study in a tertiary care centre
DOI:
https://doi.org/10.3126/ajms.v13i3.42985Keywords:
Peripartum cardiomyopathy(PPCM), Left ventricular ejection fraction(LVEF), Left ventricular internal diameter in diastole(LVIDD), New York Heart Association(NYHA), Pregnancy induced hypertension(PIH), Coronary artery disease(CAD), Chronic kidney disease(CKD), Intrauterine growth restriction(IUGR)Abstract
Background: Peripartum cardiomyopathy is a relatively rare type of dilated cardiomyopathy that presents in late pregnancy or the early postpartum period. Although the condition is prevalent worldwide, women with black genealogy seem to have greater risk. Possible other risk factors are elderly maternal age, hypertension, multiparity, multifetal pregnancy etc. Although the pathophysiology of peripartum cardiomyopathy is still obscure, recent studies suggests the important role of vasculo-hormonal pathway along with several other possible factors e.g. myocarditis, abnormal immune response to pregnancy, abnormal response to increased hemodynamic burden, malnutrition, inflammation and apoptosis .
Aims and Objectives: To find out the prevalence, risk factors and pregnancy outcome of peripartum cardiomyopathy (PPCM)
Materials and Methods: Sixty-eight patients of PPCM admitted in G&O department of RG KAR Medical college were taken. Clinical evaluations, Hematological evaluation, biochemical study, ECG and Echocardiography were done. Patient outcome was also compared between two groups of patients having Left Ventricular ejection fraction less than 35% and more than 35%.
Result: Prevalence of PPCM was 0.09%, maternal mortality was 87 per 1000 live births and perinatal mortality was 43 per 1000 live births. Patients with lower ejection fraction showed poorer outcome.
Conclusion: Patients with higher NYHA functional class, lower ejection fraction and larger left ventricular cavity showed worse maternal and perinatal outcome.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Asian Journal of Medical Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- The journal holds copyright and publishes the work under a Creative Commons CC-BY-NC license that permits use, distribution and reprduction in any medium, provided the original work is properly cited and is not used for commercial purposes. The journal should be recognised as the original publisher of this work.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
